Historically, the legal requirement for validation of pharmaceutical manufacturing processes originated in the U.S. with the Food and Drug Administration (FDA) promulgating the cGMP regulation in 1979. This precipitated a widespread rush by pharmaceutical manufacturers to install formalized validation programs suited to their individual needs, financial capabilities, and company philosophy. These regulations have been written in such a way as to leave the interpretation to the user. Confusion and misinterpretation by industry on the scope and extent of this requirement has led to ever increasing costs of bringing pharmaceutical facilities in compliance with these cGMPs. The cost of validating a facility is determined by time spent on documentation, development of protocols and Standard Operating Procedures (SOPs), and the time spent on actual fieldwork, data collection, and analysis.
For a new or upgraded facility, commissioning and facility validation is the foundation for assuring success in further manufacturing process validation. Before you begin validating a manufacturing process, an acceptable facility, and the utilities and equipment to support manufacturing operations must be in place. Facility qualification (a part of validation that proves and documents that equipment or ancillary systems are properly installed, work correctly, and actually lead to the expected results), and validation (establishing documented evidence that provides a high degree of assurance that the manufacturing processes, including buildings, systems, and equipment consistently produce the desired results according to predetermined specifications and quality attributes) activities will establish and provide documentary evidence that:
•The premises, supporting utilities, equipment, and processes have been designed in accordance with the requirements of GMP. This constitutes Design Qualification (DQ).
•The premises, supporting utilities, and equipment have been built and installed in compliance with their design specifications. This constitutes Installation Qualification (IQ).
•The facilities, supporting utilities, and equipment operate in accordance with their design specifications. This constitutes Operational Qualification (OQ).
•The facilities, utilities, or equipment that can affect product quality, performs as intended meeting predetermined acceptance criteria. This constitutes Equipment Performance Qualification (EPQ) Once the facility has been validated (IQ + OQ + Performance Qualification [pq]), then process validation can commence
•A specific process will consistently produce a product meeting predetermined specifications and quality attributes. This constitutes Process Validation (PV) or Process Performance Qualification (PPQ).
Establishing a project team that has adequate skills that are appropriate for the size and complexity of the project is key to the project launch. Project team representation should be based on the project scope, resource requirements, and key stakeholders.
Iam enclosing a basic document about Facility validation as a PDF attachment.
Facility validation.pdf (81.2 KB)